FY2026 Group Guidance of 160,000 AuEq oz to 175,000 AuEq oz production at an AISC of A$2,600 - $2,900 per AuEq oz remains ...

While American Airlines is a deeply embattled business, the prospect of a dead-cat bounce makes AAL stock intriguing for ...

Regeneron gests US FDA approval for Libtayo as an adjuvant treatment of CSCC with a high risk of recurrence after surgery and radiation: Tarrytown, New York Friday, October 10, 20 ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to ...

Approval based on pivotal Phase 3 C-POST trial showing Libtayo significantly reduced the risk of disease recurrence or death by 68% compared to placebo (hazard ratio: 0.32; 95% confidence interval: 0.

Nuvalent, Inc. ( NASDAQ: NUVL) UBS Virtual Oncology Day October 1, 2025 3:30 PM EDT Welcome to the UBS Virtual Event. David Dai, you may begin.

Recursion Pharmaceuticals trades at a $2.65bn valuation despite slow clinical progress, high cash burn, and no late-stage ...

Targeted therapies have changed non-small cell lung cancer care, but new side effects, like weight gain, are emerging, says Dr. Lorenzo Belluomini.

Claudine Isaacs, MD: For this patient who's progressed after more than 12 months with an ESR1 mutation and HER2-low disease ...

This new levy would provide critical funding to protect our waterways, to keep the Boise River and other waters clean. | ...